Tema Cardiovascular and Metabolics ETF Rating $28.70 -0.19 (-0.66%) As of 01/17/2025 03:52 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrends Tema Cardiovascular and Metabolics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.80Holdings in HRTS have an aggregate rating of Moderate Buy based on 497 analyst ratings issued in the past year covering 34 companies (81.9% of the portfolio).HRTS Aggregate Price Target$28.70High Prediction$28.70Average Prediction$28.70Low Prediction$28.70Holdings in HRTS have an aggregate price target of $28.70 and a range of $28.70 to $28.70 covering 34 companies (81.9% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Cardiovascular and Metabolics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 34 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.42%LLYEli Lilly and Company$726.24-4.1%4.9979 of 5 stars2.81$1,002.22 38.0%21High Trading Volume5.25%VRTXVertex Pharmaceuticals$422.00+1.2%4.2809 of 5 stars2.52$490.38 16.2%315.04%ALNYAlnylam Pharmaceuticals$246.27-1.2%4.4407 of 5 stars2.72$298.61 21.3%25Analyst Revision4.43%BBIOBridgeBio Pharma$33.79-0.9%4.0926 of 5 stars2.86$48.08 42.3%14Short Interest ↑High Trading Volume3.92%ASNDAscendis Pharma A/S$128.13-2.7%3.6284 of 5 stars2.93$192.07 49.9%14Short Interest ↓Analyst Revision3.83%CRNXCrinetics Pharmaceuticals$37.35+2.4%3.5964 of 5 stars3.00$74.40 99.2%10Short Interest ↑3.33%CYTKCytokinetics$45.74-2.7%4.2371 of 5 stars2.80$83.64 82.9%153.32%AMGNAmgen$272.11+1.0%4.8826 of 5 stars2.44$314.91 15.7%27Positive NewsGap Up3.00%DXCMDexCom$84.38-0.5%4.968 of 5 stars2.89$99.29 17.7%18Short Interest ↓2.83%MREOMereo BioPharma Group$2.86-1.4%2.2374 of 5 stars3.43$7.83 173.9%72.74%BSXBoston Scientific$98.73+0.6%4.6415 of 5 stars2.96$97.26 -1.5%23Short Interest ↑2.59%MIRMMirum Pharmaceuticals$46.95+2.4%3.9555 of 5 stars3.09$57.10 21.6%112.54%IONSIonis Pharmaceuticals$31.43-2.6%4.2232 of 5 stars2.68$60.65 93.0%19Insider Trade2.39%EWEdwards Lifesciences$69.77-0.1%4.3546 of 5 stars2.38$78.48 12.5%262.37%MASIMasimo$172.29+1.4%4.0356 of 5 stars2.71$179.67 4.3%72.10%PODDInsulet$275.81+1.1%4.3919 of 5 stars2.81$272.81 -1.1%162.06%MDTMedtronic$88.23+1.2%4.9354 of 5 stars2.41$95.00 7.7%17Positive News2.03%REGNRegeneron Pharmaceuticals$681.58-1.7%4.5942 of 5 stars2.65$1,015.38 49.0%231.80%GPCRStructure Therapeutics$27.06+0.3%1.5784 of 5 stars3.00$81.29 200.4%8Short Interest ↑1.73%ARWRArrowhead Pharmaceuticals$19.56+2.8%4.1906 of 5 stars2.60$43.33 121.5%101.71%RCKTRocket Pharmaceuticals$10.31+1.0%4.4928 of 5 stars2.92$47.27 358.5%121.67%MDGLMadrigal Pharmaceuticals$293.64+7.6%4.5412 of 5 stars2.69$351.67 19.8%13High Trading Volume1.65%MLYSMineralys Therapeutics$9.24-2.7%2.8502 of 5 stars3.00$30.00 224.7%3Gap Down1.56%WSTWest Pharmaceutical Services$336.15-0.3%4.9291 of 5 stars2.83$430.20 28.0%6Positive News1.43%NTLAIntellia Therapeutics$9.50+0.8%4.4838 of 5 stars2.72$51.06 437.5%181.34%AKROAkero Therapeutics$25.14+4.7%3.9357 of 5 stars2.88$46.83 86.3%81.26%TMOThermo Fisher Scientific$559.72-0.4%4.9785 of 5 stars2.86$648.95 15.9%22News CoveragePositive News1.22%VKTXViking Therapeutics$32.65+0.3%3.9311 of 5 stars3.15$106.75 227.0%13Analyst Forecast1.13%NARIInari Medical$79.55+0.2%1.6947 of 5 stars2.14$68.00 -14.5%141.10%INSMInsmed$72.51-0.3%3.1334 of 5 stars3.00$83.67 15.4%16Short Interest ↑0.89%SLNOSoleno Therapeutics$46.88+1.9%4.3635 of 5 stars3.14$74.83 59.6%70.84%KROSKeros Therapeutics$10.86+3.2%3.2136 of 5 stars2.64$52.56 383.9%14Gap DownHigh Trading Volume0.75%VERVVerve Therapeutics$6.14+0.7%2.7623 of 5 stars3.00$25.75 319.4%40.66%TERNTerns Pharmaceuticals$4.43-1.6%3.8007 of 5 stars2.80$18.30 313.1%5 This page (NASDAQ:HRTS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts